The therapeutic landscape of HIV-1 via genome editing

about

Interferons and beyond: Induction of antiretroviral restriction factors.Dissecting the Role of Disturbed ER-Golgi Trafficking in Antivirals and Alcohol Abuse-Induced Pathogenesis of Liver Disorders.

P2860

Q47552023-A9FFF0F7-A979-42CF-8366-E93A9E414DE9 Q49331824-52EFE2BC-4B9E-4DE5-8944-8E326FE8F5C8

P2860

The therapeutic landscape of HIV-1 via genome editing

Item

http://www.wikidata.org/entity/Q39153976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The therapeutic landscape of HIV-1 via genome editing

@en

The therapeutic landscape of HIV-1 via genome editing.

@nl

type

Item

label

The therapeutic landscape of HIV-1 via genome editing

@en

The therapeutic landscape of HIV-1 via genome editing.

@nl

prefLabel

The therapeutic landscape of HIV-1 via genome editing

@en

The therapeutic landscape of HIV-1 via genome editing.

@nl

P1476

The therapeutic landscape of HIV-1 via genome editing

@en

P2093

Alexander Kwarteng

http://www.w3.org/2001/XMLSchema#string

Godwin Kwakye-Nuako

http://www.w3.org/2001/XMLSchema#string

Samuel Terkper Ahuno

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.

Multiplex genome engineering using CRISPR/Cas systems

Newer gene editing technologies toward HIV gene therapy

Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system

Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome

HIV-1 nef suppression by virally encoded microRNA

Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5

Targeting the latent reservoir to achieve functional HIV cure

P2888

s12981-017-0157-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12981-017-0157-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Godwin Kwakye-Nuako

Samuel Ahuno

Alexander Kwarteng

P5008

ScienceSource

P577

2017-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090673472

http://www.w3.org/2001/XMLSchema#string

P698

28705213

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

endonuclease

recombinant protein

biomedical investigative technique

Anzim

P932

5513397

http://www.w3.org/2001/XMLSchema#string

The therapeutic landscape of HIV-1 via genome editing

about

P2860

P2860

The therapeutic landscape of HIV-1 via genome editing

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932